{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:25Z","timestamp":1790649865962,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02850-2","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:21:19Z","timestamp":1772436079000},"page":"1509-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Different clinical autoimmune polyglandular syndrome phenotypes among patients with thyroid diseases"],"prefix":"10.1007","volume":"49","author":[{"given":"Elisa","family":"Gatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Virili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Centanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1232","authenticated-orcid":false,"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2850_CR1","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.12688\/f1000research.11535.1","volume":"6","author":"S Bliddal","year":"2017","unstructured":"Bliddal S, Nielsen CH, Feldt-Rasmussen U (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res 6:1776. https:\/\/doi.org\/10.12688\/f1000research.11535.1","journal-title":"F1000Res"},{"issue":"5","key":"2850_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1530\/acta.0.1230493","volume":"123","author":"LM Prentice","year":"1990","unstructured":"Prentice LM, Phillips DI, Sarsero D, Beever K, McLachlan SM, Smith BR (1990) Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh) 123(5):493\u2013498. https:\/\/doi.org\/10.1530\/acta.0.1230493","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"2850_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/acta.0.1140321","volume":"114","author":"C Betterle","year":"1987","unstructured":"Betterle C, Callegari G, Presotto F, Zanette F, Pedini B, Rampazzo T, Slack RS, Girelli ME, Busnardo B (1987) Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis. Acta Endocrinol (Copenh) 114(3):321\u2013327. https:\/\/doi.org\/10.1530\/acta.0.1140321","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"2850_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DS McLeod","year":"2012","unstructured":"McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2):252\u2013265. https:\/\/doi.org\/10.1007\/s12020-012-9703-2","journal-title":"Endocrine"},{"issue":"4","key":"2850_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160(4):526\u2013534. https:\/\/doi.org\/10.1001\/archinte.160.4.526","journal-title":"Arch Intern Med"},{"issue":"1\u20133","key":"2850_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12026-009-8153-2","volume":"47","author":"WW Eaton","year":"2010","unstructured":"Eaton WW, Pedersen MG, Atladottir HO, Gregory PE, Rose NR, Mortensen PB (2010) The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res 47(1\u20133):228\u2013231. https:\/\/doi.org\/10.1007\/s12026-009-8153-2","journal-title":"Immunol Res"},{"issue":"16","key":"2850_CR7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L (2016) Graves\u2019 Disease. N Engl J Med 375(16):1552\u20131565. https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N Engl J Med"},{"issue":"2","key":"2850_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P (2015) Autoimmune thyroid disorders. Autoimmun Rev 14(2):174\u2013180. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.016","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2850_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1086\/378588","volume":"73","author":"Y Tomer","year":"2003","unstructured":"Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73(4):736\u2013747. https:\/\/doi.org\/10.1086\/378588","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2850_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1210\/er.2002-0030","volume":"24","author":"Y Tomer","year":"2003","unstructured":"Tomer Y, Davies TF (2003) Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24(5):694\u2013717. https:\/\/doi.org\/10.1210\/er.2002-0030","journal-title":"Endocr Rev"},{"key":"2850_CR11","doi-asserted-by":"publisher","unstructured":"Wro\u0144ska K, Ha\u0142asa M, Szczuko M (2024) The Role of the Immune System in the Course of Hashimoto\u2019s Thyroiditis: The Current State of Knowledge. Int J Mol Sci 25(13). https:\/\/doi.org\/10.3390\/ijms25136883","DOI":"10.3390\/ijms25136883"},{"key":"2850_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cyto.2019.01.003","volume":"116","author":"J Luty","year":"2019","unstructured":"Luty J, Ruckemann-Dziurdzi\u0144ska K, Witkowski JM, Bryl E (2019) Immunological aspects of autoimmune thyroid disease - Complex interplay between cells and cytokines. Cytokine 116:128\u2013133. https:\/\/doi.org\/10.1016\/j.cyto.2019.01.003","journal-title":"Cytokine"},{"key":"2850_CR13","unstructured":"Gershwin ME, Tsokos GC, Diamond B (2024) The Rose and Mackay textbook of autoimmune diseases. Elsevier"},{"issue":"4","key":"2850_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.1999.9.333","volume":"9","author":"M Okumura","year":"1999","unstructured":"Okumura M, Hidaka Y, Matsuzuka F, Takeoka K, Tada H, Kuma K, Amino N (1999) CD30 expression and interleukin-4 and interferon-gamma production of intrathyroidal lymphocytes in Graves\u2019 disease. Thyroid 9(4):333\u2013339. https:\/\/doi.org\/10.1089\/thy.1999.9.333","journal-title":"Thyroid"},{"issue":"6","key":"2850_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/eje-07-0019","volume":"156","author":"Y Inukai","year":"2007","unstructured":"Inukai Y, Momobayashi A, Sugawara N, Aso Y (2007) Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves\u2019 disease. Eur J Endocrinol 156(6):623\u2013630. https:\/\/doi.org\/10.1530\/eje-07-0019","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2850_CR16","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1210\/jc.2014-3011","volume":"99","author":"B Rapoport","year":"2014","unstructured":"Rapoport B, McLachlan SM (2014) Graves\u2019 hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab 99(11):4060\u20134061","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2850_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s40618-023-02200-6","volume":"47","author":"E Gatta","year":"2024","unstructured":"Gatta E, Maltese V, Cimino E, Cavadini M, Anelli V, Di Lodovico E, Piovani E, Zammarchi I, Gozzoli G, Agosti B, Pirola I, Delbarba A, Girelli A, Buoso C, Bambini F, Alfieri D, Bremi W, Facondo P, Lupo R, Bezzi F, Fredi M, Mazzola AM, Gandossi E, Saullo M, Marini F, Licini M, Pezzaioli LC, Pini L, Franceschini F, Ricci C, Cappelli C (2024) Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications. J Endocrinol Invest 47(4):857\u2013864. https:\/\/doi.org\/10.1007\/s40618-023-02200-6","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2850_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","volume":"9","author":"M Neufeld","year":"1980","unstructured":"Neufeld M, Maclaren N, Blizzard R (1980) Autoimmune polyglandular syndromes. Pediatr Ann 9(4):154\u2013162","journal-title":"Pediatr Ann"},{"key":"2850_CR19","unstructured":"Betterle C, Presotto F, Walker S, Jara L (2008) Handbook of Systemic Autoimmune Diseases. Endocrine Manifestations of Systemic Autoimmune Diseases. Chapter 6, pp 61\u201373"},{"issue":"2\u20133","key":"2850_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","volume":"28","author":"EM Jacobson","year":"2007","unstructured":"Jacobson EM, Tomer Y (2007) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28(2\u20133):85\u201398. https:\/\/doi.org\/10.1016\/j.jaut.2007.02.006","journal-title":"J Autoimmun"},{"issue":"4","key":"2850_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40618-022-01994-1","volume":"46","author":"C Betterle","year":"2023","unstructured":"Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F (2023) Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest 46(4):643\u2013665. https:\/\/doi.org\/10.1007\/s40618-022-01994-1","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 1","key":"2850_CR22","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"Classification and Diagnosis of Diabetes","year":"2021","unstructured":"Classification and Diagnosis of Diabetes (2021) Standards of Medical Care in Diabetes-2021. Diabetes Care 44(Suppl 1):S15\u2013s33. https:\/\/doi.org\/10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"issue":"9","key":"2850_CR23","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"Marazuela M, Garc\u00eda-L\u00f3pez MA, Figueroa-Vega N, de la Fuente H, Alvarado-S\u00e1nchez B, Monsiv\u00e1is-Urenda A, S\u00e1nchez-Madrid F, Gonz\u00e1lez-Amaro R (2006) Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91(9):3639\u20133646","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2850_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2265.1992.tb00960.x","volume":"36","author":"Z Kraiem","year":"1992","unstructured":"Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36(2):211\u2013214. https:\/\/doi.org\/10.1111\/j.1365-2265.1992.tb00960.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2850_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-018-0046-9","volume":"11","author":"M Rydzewska","year":"2018","unstructured":"Rydzewska M, Jaromin M, Pasierowska IE, Sto\u017cek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11:2. https:\/\/doi.org\/10.1186\/s13044-018-0046-9","journal-title":"Thyroid Res"},{"issue":"2","key":"2850_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.amjmed.2009.06.030","volume":"123","author":"K Boelaert","year":"2010","unstructured":"Boelaert K, Newby P, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123(2):183\u2013e1. https:\/\/doi.org\/10.1016\/j.amjmed.2009.06.030","journal-title":"Am J Med"},{"issue":"5","key":"2850_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1530\/EJE-10-1172","volume":"164","author":"J Wiebolt","year":"2011","unstructured":"Wiebolt J, Achterbergh R, den Boer A, van der Leij S, Marsch E, Suelmann B, de Vries R, van Haeften TW (2011) Clustering of additional autoimmunity behaves differently in Hashimoto\u2019s patients compared with Graves\u2019 patients. Eur J Endocrinol 164(5):789\u2013794. https:\/\/doi.org\/10.1530\/EJE-10-1172","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2850_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10067-005-1165-y","volume":"25","author":"E Biro","year":"2006","unstructured":"Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, Szucs G, Zeher M, Bodolay E, Szegedi G, Bako G (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25(2):240\u2013245. https:\/\/doi.org\/10.1007\/s10067-005-1165-y","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2850_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/EJE-16-0737","volume":"176","author":"RM Ruggeri","year":"2017","unstructured":"Ruggeri RM, Trimarchi F, Giuffrida G, Certo R, Cama E, Campenni A, Alibrandi A, De Luca F, Wasniewska M (2017) Autoimmune comorbidities in Hashimoto\u2019s thyroiditis: different patterns of association in adulthood and childhood\/adolescence. Eur J Endocrinol 176(2):133\u2013141. https:\/\/doi.org\/10.1530\/EJE-16-0737","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2850_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23(1):14\u201324. https:\/\/doi.org\/10.1089\/thy.2012.0374","journal-title":"Thyroid"},{"issue":"2","key":"2850_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40618-019-01094-7","volume":"43","author":"M Rotondi","year":"2020","unstructured":"Rotondi M, Virili C, Pinto S, Coperchini F, Croce L, Brusca N, Centanni M, Chiovato L (2020) The clinical phenotype of Graves\u2019 disease occurring as an isolated condition or in association with other autoimmune diseases. J Endocrinol Invest 43(2):157\u2013162. https:\/\/doi.org\/10.1007\/s40618-019-01094-7","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2850_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellimm.2015.02.004","volume":"294","author":"A Trigunaite","year":"2015","unstructured":"Trigunaite A, Dimo J, J\u00f8rgensen TN (2015) Suppressive effects of androgens on the immune system. Cell Immunol 294(2):87\u201394. https:\/\/doi.org\/10.1016\/j.cellimm.2015.02.004","journal-title":"Cell Immunol"},{"issue":"11","key":"2850_CR33","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/art.1780221105","volume":"22","author":"ED Murphy","year":"1979","unstructured":"Murphy ED, Roths JB (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 22(11):1188\u20131194. https:\/\/doi.org\/10.1002\/art.1780221105","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2850_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/oxfordjournals.bmb.a070671","volume":"25","author":"CO Carter","year":"1969","unstructured":"Carter CO (1969) Genetics of common disorders. Br Med Bull 25(1):52\u201357. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a070671","journal-title":"Br Med Bull"},{"issue":"5","key":"2850_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/BOR.0b013e328277ef2a","volume":"19","author":"AB Pernis","year":"2007","unstructured":"Pernis AB (2007) Estrogen and CD4\u2009+\u2009T cells. Curr Opin Rheumatol 19(5):414\u2013420. https:\/\/doi.org\/10.1097\/BOR.0b013e328277ef2a","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2850_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0606391","volume":"81","author":"AJ Lengi","year":"2007","unstructured":"Lengi AJ, Phillips RA, Karpuzoglu E, Ahmed SA (2007) Estrogen selectively regulates chemokines in murine splenocytes. J Leukoc Biol 81(4):1065\u20131074. https:\/\/doi.org\/10.1189\/jlb.0606391","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2850_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jcp.21221","volume":"214","author":"P Tai","year":"2008","unstructured":"Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, Zhao L, An X, Du X, Chen X, Wang S, Xia G, Wang B (2008) Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 214(2):456\u2013464. https:\/\/doi.org\/10.1002\/jcp.21221","journal-title":"J Cell Physiol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02850-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:25:07Z","timestamp":1786105507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02850-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2850"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02850-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}